The recent announcement that a monoclonal antibody can slow the cognitive decline of Alzhimer’s patients is a reason for hope.
Latest drug breakthrough a reason for hope, and more funding
- Post author:admin
- Post published:December 4, 2022
- Post category:Uncategorized